Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Braz. j. infect. dis ; 7(1): 44-61, Feb. 2003. ilus, tab
Article Dans Anglais | LILACS | ID: lil-351145

Résumé

PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) is a global surveillance study established in 1999 to monitor antibacterial resistance of respiratory tract organisms. Thirteen centers from Argentina, Brazil and Mexico participat ed during 1999-2000; they collected 1,806 isolates (Streptococcus pneumoniae 518, Haemophilus influenzae 520, Moraxella catarrhalis 140, Staphylococcus aureus 351, S. pyogenes 277). Overall, 218 (42.1 percent) of the S. pneumoniae isolates had reduced susceptibility to penicillin, 79 (15.3 percent) were penicillin-resistant and 79 (15.3 percent) were erythromycin-resistant. Mexico had the highest prevalence of penicillin (76.5 percent) and erythromycin (31.2 percent) resistance. Of 77 erythromycin-resistant S. pneumoniae tested for resistance genotype, 43 possessed mef(A), 33 possessed erm(B) and 1 possessed both erm(B) and mef(A) mechanism. All S. pneumoniae isolates were fully susceptible to telithromycin, linezolid, teicoplanin and vancomycin. Among H. influenzae isolates, 88 (16.9 percent) produced b-lactamase, ranging from 11 percent (Brazil) to 24.5 percent (Mexico). Among M. catarrhalis isolates, 138 (98.6 percent) produced b-lactamase. Twenty-four (8.7 percent) of the S. pyogenes isolates were erythromycin-resistant; resistance being attributable to mefA (n=18), ermTR (n=5) and ermB (n=1). All H. influenzae, M. catarrhalis and S. pyogenes were fully susceptible to telithromycin. Methicillin resistance was found in 26.5 percent of the S. aureus isolates (Argentina 15 percent; Mexico 20 percent; Brazil 31.3 percent). Telithromycin was effective against 97.7 percent of methicillin-susceptible isolates. PROTEKT confirms that antibacterial resistance is an emerging problem in Latin America. The previously reported high levels of pneumococcal resistance to the b-lactam and macrolides were exceeded. New agents that do not induce resistance or that exert low selective pressure, e.g. telithromycin, are essential to safeguard future antibacterial efficacy


Sujets)
Humains , Antibactériens/usage thérapeutique , Érythromycine/usage thérapeutique , Résistance aux pénicillines , Infections de l'appareil respiratoire/traitement médicamenteux , Antibactériens/pharmacologie , Argentine/épidémiologie , Brésil/épidémiologie , Infections communautaires/traitement médicamenteux , Infections communautaires/épidémiologie , Infections communautaires/microbiologie , Multirésistance aux médicaments , Érythromycine/pharmacologie , Bactéries à Gram négatif/effets des médicaments et des substances chimiques , Bactéries à Gram positif/effets des médicaments et des substances chimiques , Haemophilus influenzae/effets des médicaments et des substances chimiques , Haemophilus influenzae/isolement et purification , Tests de sensibilité microbienne , Mexique/épidémiologie , Moraxella catarrhalis/effets des médicaments et des substances chimiques , Moraxella catarrhalis/isolement et purification , Surveillance de la population , Infections de l'appareil respiratoire/épidémiologie , Infections de l'appareil respiratoire/microbiologie , Staphylococcus aureus/effets des médicaments et des substances chimiques , Staphylococcus aureus/isolement et purification , Streptococcus pneumoniae/effets des médicaments et des substances chimiques , Streptococcus pneumoniae/isolement et purification , Streptococcus pyogenes/effets des médicaments et des substances chimiques , Streptococcus pyogenes/isolement et purification
2.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 42(4): 205-14, out.-dez. 1996. tab
Article Dans Portugais | LILACS | ID: lil-186406

Résumé

OBJETIVO. Determinar a incidência, a etiologia e os fatores de risco das infecçoes relacionadas ao cateter venoso central em terapia intensiva. METODOLOGIA. Estudo observacional de coorte, prospectivo, em pacientes criticamente enfermos submetidos à cateterizaçao venosa profunda por punçao percutânea. Realizadas culturas quantitativa da pele, semiquantitativa da ponta e quantitativa do canhao do cateter, e hemocultura periférica. Os possíveis fatores de risco foram submetidos à análise univariada e multivariada. RESULTADOS. Foram estudados 57 períodos de cateterizaçao em 51 pacientes. A incidência de infecçao local foi de 21,1 por cento (33,8/1.000 dias-cateter), e de bacteremia, 8,7 por cento (l4,1/1.000 dias-cateter). A pele no local de inserçao estava colonizada em 32,7 por cento dos pacientes e o canhao, em 29,1 por cento. A origem dos microrganismos causadores de infecçao foi a pele em 41,2 por cento, o canhao em 29,4 por cento, infecçao a distância em 5,9 por cento, e nao ficou esclarecida em 23,5 por cento dos casos. Estafilococos coagulase-negativa foram os agentes etiológicos predominantes. Identificou-se, como variáveis independentemente associadas à infecçao local, a purulência no orifício de inserçao e a utilizaçao de outro dispositivo intravascular. As variáveis independentemente associadas à bacteremia foram a inserçao na veia jugular interna e a colonizaçao do canhao do cateter. CONCLUSOES. A bacteremia é uma complicaçao importante do cateterismo venoso central em terapia intensiva. Os estafilococos coagulase-negativa predominam nesta modalidade de infecçao hospitalar. A inserçao do cateter na veia jugular interna e a colonizaçao do canhao aumentam o risco de bacteremia relacionada à linha venosa central.


Sujets)
Humains , Femelle , Sujet âgé , Cathétérisme veineux central/effets indésirables , Infection croisée/épidémiologie , Infection croisée/complications , Infection croisée/étiologie , Incidence , Études prospectives , Facteurs de risque , Analyse de variance , Études de cohortes , Unités de soins intensifs , Plasmides lactose
SÉLECTION CITATIONS
Détails de la recherche